Retractable Technologies (RVP) Common Equity (2010 - 2026)
Retractable Technologies' (RVP) quarterly Common Equity came in at $70.1 million in Q1 2026, down 8.51% YoY from $76.6 million in Q1 2025, and down 5.76% on a QoQ basis from $74.4 million in Q4 2025.
Retractable Technologies (RVP) Common Equity (2010 - 2026) Analysis & Trends
Retractable Technologies (RVP) has 17 years of Common Equity data on file, last reported at $70.1 million in Q1 2026.
- Quarterly Common Equity fell 8.51% year-over-year to $70.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $70.1 million (down 8.51% YoY) and the FY2025 annual result came in at $74.4 million, down 14.68% from the prior year.
- Common Equity declined to $70.1 million in Q1 2026, from $74.4 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $109.0 million in Q3 2022 to a low of $70.1 million in Q1 2026.
- A 5-year average of $91.9 million and a median of $99.3 million in 2023 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2022 — Common Equity surged 55.25% — and 2025, when it dropped 23.13%.
- Tracing RVP's Common Equity over 5 years: stood at $106.5 million in 2022, then retreated by 6.8% to $99.3 million in 2023, then dropped by 12.2% to $87.2 million in 2024, then decreased by 14.68% to $74.4 million in 2025, then fell by 5.76% to $70.1 million in 2026.
- The last three Common Equity figures came in at $70.1 million (Q1 2026), $74.4 million (Q4 2025), and $76.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 18.30 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 24.42 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 21.60 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 6.59 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 19.08 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 2.99 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 4.80 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 8.24 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 6.21 Bn |
| 10 | Retractable Technologies | 21.84 Mn | -18.03 Mn | 190,852.00 | 72.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.09 Mn |
| Dec 31, 2025 | 74.38 Mn |
| Sep 30, 2025 | 76.78 Mn |
| Jun 30, 2025 | 76.47 Mn |
| Mar 31, 2025 | 76.61 Mn |
| Dec 31, 2024 | 87.17 Mn |
| Sep 30, 2024 | 83.46 Mn |
| Jun 30, 2024 | 85.44 Mn |
| Mar 31, 2024 | 99.66 Mn |
| Dec 31, 2023 | 99.29 Mn |
| Sep 30, 2023 | 99.42 Mn |
| Jun 30, 2023 | 103.54 Mn |
| Mar 31, 2023 | 107.47 Mn |
| Dec 31, 2022 | 106.54 Mn |
| Sep 30, 2022 | 108.98 Mn |
| Jun 30, 2022 | 102.50 Mn |
| Mar 31, 2022 | 105.32 Mn |
| Dec 31, 2021 | 99.17 Mn |
| Sep 30, 2021 | 79.60 Mn |
| Jun 30, 2021 | 74.64 Mn |